Extracorporeal Life Support for Cardiogenic Shock with Either A Percutaneous Ventricular Assist Device or An Intra-Aortic Balloon Pump
Careful considerations are required before selecting an additional support to ECLS.
Outcomes of Cardiac Surgery in Jehovah’s Witness Patients: A Review.
The use of a bloodless protocol for Jehovah’s Witnesses does not appear to significantly impact upon clinical outcomes when compared to non-Witness patients, and it has even been suggested that a bloodless approach could provide advantages to all patients undergoing cardiac surgery. Larger cohorts and research across multiple centres into the long term outcomes of these patients is required.
Perioperative Cardioprotection: General Mechanisms and Pharmacological Approaches
This review presents the fundamental mechanisms of conditioning strategies and provides an overview of the most recent and relevant findings on different concepts achieving cardioprotection in the experimental setting, specifically emphasizing pharmacological approaches in the perioperative context.
International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
After discussion of the scoping reviews and the evidence update, the task force prioritized several topics for new systematic reviews.
Pediatric Intensive Care Preparedness and ECMO Availability in Children With COVID-19: An International Survey
In conclusion, both the experience in managing patients and the availability of neonatal/pediatric ECMO in the centers the responders are working seemed to increase physicians’ preparedness.
Prompt Prediction of Fibrinogen Concentration During Cardiopulmonary Bypass: A Pilot Study
Our results indicate a strong correlation between fibrinogen activation and serum fibrinogen concentration. The maximum amplitude of activator f can estimate low fibrinogen concentration faster than traditional methods; this method quickly provides important information for anesthesia and hemostatic management in cardiac surgery.
Efficacy and Safety of Corticosteroids Prophylaxis in Cardiac Surgery: A Protocol for Systematic Review and Meta-Analysis
This study will compare the efficacy of prophylactic corticosteroids for adults and children undergoing cardiac surgery with CPB. Due to the nature of the disease and intervention methods, randomized controlled trials may be inadequate, and we will carefully consider inclusion in high-quality, non-randomized controlled trials, but this may result in high heterogeneity and affect the reliability of the results.
Anesthesiology Research Using Surgical Registries: Consider the Source
Anesthesiologists should take a lead role in studying this specialty and should be involved in development and maintenance of surgical specialty databases and quality improvement initiatives. The reliability of the data is at stake.
Exposure–Response Relationship of Tranexamic Acid in Cardiac Surgery: A Model-based Meta-analysis
In cardiopulmonary bypass surgery, low-dose tranexamic acid seems to be an appropriate regimen for reducing bleeding outcomes. This meta-analysis has to be interpreted with caution because the results are observational and dependent on the lack of bias of the predicted tranexamic acid exposures and the quality of the included studies.
Impact of Corticosteroids on Cardiopulmonary Bypass Induced Inflammation in Children:A Meta-Analysis
CS were found to have a favorable impact on postoperative fluid balance and may be associated with shortening the duration of mechanical ventilation. While CS had no impact on mortality, they may be beneficial, particularly in neonates and those undergoing high complexity surgery.
Effects of Remote Ischemic Preconditioning on Platelet Activation and Reactivity in Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass: A Randomized Controlled Trial
RIPC did not alter platelet activation and reactivity during CPB in patients undergoing cardiac surgery.
Artificial Lungs–Where Are We Going with The Lung Replacement Therapy?
Recent progress in artificial lung technologies includes continued advances in both engineering and biology. The final goal is to achieve a truly implantable and durable artificial lung that is applicable to destination therapy.